ATAT vs. NBIX
ATAT (Atour Lifestyle Holdings Limited) and NBIX (Neurocrine Biosciences, Inc.) are both stocks. ATAT operates in Lodging (Consumer Cyclical), while NBIX operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 3 years, ATAT returned 22.34%/yr vs 17.27%/yr for NBIX. Their 0.11 correlation means their historical movements had little consistent relationship.
Performance
ATAT vs. NBIX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ATAT achieves a -11.46% return, which is significantly lower than NBIX's 17.61% return.
ATAT
- 1D
- 0.26%
- 1M
- 4.44%
- 6M
- -2.40%
- YTD
- -11.46%
- 1Y
- 4.02%
- 3Y*
- 22.34%
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 26.14%
NBIX
- 1D
- -10.08%
- 1M
- -0.58%
- 6M
- 22.59%
- YTD
- 17.61%
- 1Y
- 30.08%
- 3Y*
- 17.27%
- 5Y*
- 12.34%
- 10Y*
- 12.71%
- ALL TIME*
- 9.11%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $28.26M | $28.42M | $34.53M | |
| $278.93M | $232.17M | $211.02M |
ATAT vs. NBIX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
ATAT Atour Lifestyle Holdings Limited | -11.46% | 49.78% | 58.43% | -2.92% | 16.26% |
NBIX Neurocrine Biosciences, Inc. | 17.61% | 3.90% | 3.60% | 10.31% | -3.07% |
Correlation
The correlation between ATAT and NBIX is 0.12, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.12 |
Correlation (3Y) Balances recent behavior with more history. | 0.11 |
Correlation (All Time) Calculated using the full available price history since Nov 11, 2022 | 0.11 |
Fundamentals
ATAT:
$4.74B
NBIX:
$16.77B
ATAT:
CN¥13.16
NBIX:
$6.84
ATAT:
17.61
NBIX:
24.39
ATAT:
0.11
NBIX:
0.48
ATAT:
3.03
NBIX:
5.10
ATAT:
8.73
NBIX:
4.35
ATAT:
CN¥10.65B
NBIX:
$3.37B
ATAT:
CN¥4.63B
NBIX:
$3.31B
ATAT:
CN¥2.46B
NBIX:
$940.50M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ATAT vs. NBIX — Risk / Return Rank
ATAT
NBIX
ATAT vs. NBIX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Atour Lifestyle Holdings Limited (ATAT) and Neurocrine Biosciences, Inc. (NBIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ATAT | NBIX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.81 | ||
| Sortino ratioReturn per unit of downside risk | -0.94 | ||
| Omega ratioGain probability vs. loss probability | 1.05 | 1.19 | -0.14 |
| Calmar ratioReturn relative to maximum drawdown | 0.15 | 1.45 | -1.29 |
| Martin ratioReturn relative to average drawdown | 0.31 | 3.18 | -2.87 |
Loading charts...
Drawdowns
ATAT vs. NBIX - Drawdown Comparison
The maximum ATAT drawdown since its inception was -46.91%, smaller than the maximum NBIX drawdown of -97.21%. Use the drawdown chart below to compare losses from any high point for ATAT and NBIX.
Loading charts...
Drawdown Indicators
| ATAT | NBIX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -46.91% | -97.21% | +50.30% |
Max Drawdown (1Y)Largest decline over 1 year | -26.49% | -20.90% | -5.59% |
Max Drawdown (3Y)Largest decline over 3 years | -30.96% | -42.89% | +11.93% |
Max Drawdown (5Y)Largest decline over 5 years | — | -42.89% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -46.39% | — |
Current DrawdownCurrent decline from peak | -18.67% | -10.08% | -8.59% |
Average DrawdownAverage peak-to-trough decline | -20.18% | -43.66% | +23.48% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.02% | 9.47% | +3.55% |
Volatility
ATAT vs. NBIX - Volatility Comparison
The current volatility for Atour Lifestyle Holdings Limited (ATAT) is 10.43%, while Neurocrine Biosciences, Inc. (NBIX) has a volatility of 14.12%. This indicates that ATAT experiences smaller price fluctuations and is considered to be less risky than NBIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ATAT | NBIX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.43% | 14.12% | -3.69% |
Volatility (6M)Calculated over the trailing 6-month period | 27.47% | 26.01% | +1.46% |
Volatility (1Y)Calculated over the trailing 1-year period | 38.63% | 33.74% | +4.89% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 58.26% | 33.17% | +25.09% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 58.26% | 39.18% | +19.08% |
Dividends
ATAT vs. NBIX - Dividend Comparison
ATAT's dividend yield for the trailing twelve months is around 2.62%, while NBIX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
ATAT Atour Lifestyle Holdings Limited | 2.62% | 1.98% | 1.67% | 0.86% |
NBIX Neurocrine Biosciences, Inc. | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
ATAT vs. NBIX - Financials Comparison
This section allows you to compare key financial metrics between Atour Lifestyle Holdings Limited and Neurocrine Biosciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ATAT vs. NBIX - Profitability Comparison
ATAT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Atour Lifestyle Holdings Limited reported a gross profit of 1.16B and revenue of 2.79B. Therefore, the gross margin over that period was 41.4%.
NBIX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Neurocrine Biosciences, Inc. reported a gross profit of 935.80M and revenue of 959.00M. Therefore, the gross margin over that period was 97.6%.
ATAT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Atour Lifestyle Holdings Limited reported an operating income of 568.24M and revenue of 2.79B, resulting in an operating margin of 20.3%.
NBIX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Neurocrine Biosciences, Inc. reported an operating income of 151.50M and revenue of 959.00M, resulting in an operating margin of 15.8%.
ATAT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Atour Lifestyle Holdings Limited reported a net income of 460.55M and revenue of 2.79B, resulting in a net margin of 16.5%.
NBIX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Neurocrine Biosciences, Inc. reported a net income of 144.40M and revenue of 959.00M, resulting in a net margin of 15.1%.
Frequently Asked Questions
ATAT and NBIX have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NBIX has higher volatility (14.12%) compared to ATAT (10.43%). In terms of maximum drawdown, ATAT dropped -46.91% vs NBIX's -97.21%.
NBIX currently has the higher Sharpe Ratio (0.91 vs 0.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ATAT and NBIX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer